Dr. von Allmen is the Senior Vice President of Surgical Services and Surgeon-in-Chief at Cincinnati Children's Hospital Medical Center. Additionally, Dr. von Allmen holds the Lester W. Martin Chair of Pediatric Surgery. His special clinical interests include pediatric surgical oncology, pediatric inflammatory bowel disease, esophageal disorders, surgical innovation and surgical robotics. He has been a long term participant in the Surgical Section of the Children's Oncology group, the Crohn's and Colitis Foundation of America and the International Pediatric Endosurgery Group.
Dr. Ehrlich is board certified in Pediatric Surgery. Dr. Ehrlich's is recognized as a world expert in the treatment of children with Wilms and Renal tumors. Dr. Ehrlich is the chair of Surgery for Renal tumors and Hodgkin's lymphoma for the National Institute of Health Children's Oncology Group. Dr. Ehrlich also serves as Director of Pediatric Trauma at CS Mott Children's Hospital at the University of Michigan and Co lead of the Pediatric Colorectal Program. Ann Arbor, Michigan.
Medical Director of The Integrative Therapies Program for Children with Cancer. She is an Associate Professor of Clinical Pediatrics at Columbia University Medical Center, Children's Hospital of New York- Presbyterian, New York, New York.
Medical Director, Kidney and Liver Tumors ProgramCo-Medical Director, Retinoblastoma ProgramAssociate Professor, UC Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, Ohio
Professor of Paediatric Surgery and HeadPaediatric Surgical Centre of AmsterdamEmma Children's Hospital AMC and VU University Medical CentreAmsterdam, The Netherlands
Internal Medicine, OSF Healthcare System, Pioria, Illinois
Pediatric Surgery, Primary Children’s Medical Center, Salt Lake City, Utah
Associate Professor in both the Department of Pediatric Surgery at The University of Texas Medical School at Houston and in Surgical Oncology and Pediatrics at the University of Texas, Anderson Cancer Center, Houston, Texas
Co-Director of Neuroblastoma Research GroupSurgical Co-Investigator, Pediatric Oncology Group Professor of Pediatrics Professor of Surgery, Texas Children's Clinical Care Center. Houston, Texas
Professor of Surgery and Executive Director, Medical Innovation Center, University of Michigan Health System. Ann Arbor, Michigan.
Chief, Pediatric Surgical Service; Joseph H. Burchenal Chair in Pediatrics. Memorial Sloan-Kettering Cancer Center, New York, New York.
Assistant in SurgeryChief of Division, Pediatric Surgery, Boston University School of Medicine. Boston, Massachusetts.
Professor of Radiology, University of Washington. Seattle, Washington
Director Divisional Research, Akron Children's Hospital, Akron, Ohio
University Hospital Hoppe-Seyler StrasseTuebingen, Germany
Consultant Pediatric Surgery, University of Rome, Italy.
Associate Professor of Surgery, Dept of Pediatric Surgery, Marciniak Hospital, Wroclaw, Poland.
Robert Shamberger received his MD from Harvard Medical School. He completed an internship and residency in surgery at the Massachusetts General Hospital and a fellowship in pediatric surgery at Children's Hospital Boston and a surgical oncology fellowship at the National Cancer Institute, Bathesda, MD.
Director of the Division of Pediatric Urology, surgeon-in-chief at Connecticut Children's Medical Center and vice chairman of the Department of Surgery at UConn Health Center. Hartford, Connecticut
Pediatric Surgeon at St. Jude Children's Research HospitalSt. Jude Endowed Chair in Surgical ResearchDivision Chief, General Pediatric SurgeryDirector, Surgical Research. Memphis, Tennessee.
Lymph node dissection
Open versus Percutaneous Biopsy
Adjunvant therapy at surgery
Timing of Surgery
Role of surgery relapse
Role of Mastectomy in pediatric solid tumors
Regionalization of oncology care
The participants will learn how to better diagnose and obtain confirming pathology of Wilms’ tumor using open vs. percutaneous methods of biopsy. Indications and advantages/disadvantages of partial nephrectomy will be outlined. Participants will understand the methods and technique of lymph node dissection.
Participants will recognize the differences between the need for aggressive surgery and adjuvent therapies. They will also understand the optimal timing of surgery and its role in the management of relapse. Promising new therapies will be explored.
Participants will learn the role of metastectomy in pediatric solid tumors as well as regionalization of oncology care. AYA protocols will be discussed and participants will understand their use in adolescents.
TM. Physicians should claim only the credit commensurate with the extent of their participation in this activity.